SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000921895-21-000600
Filing Date
2021-03-02
Accepted
2021-03-02 17:34:36
Documents
2
Period of Report
2021-02-26

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT form312566002_03022021.html 3  
1 OWNERSHIP DOCUMENT form312566002_03022021.xml 3 1613
2 ex24toform312566002_03022021.htm EX-24 6810
  Complete submission text file 0000921895-21-000600.txt   9972
Mailing Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142
Business Address ONE BROADWAY 14TH FLOOR CAMBRIDGE MA 02142 617-514-7149
Summit Therapeutics Inc. (Issuer) CIK: 0001599298 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address ONE BROADWAY, 14TH FLOOR CAMBRIDGE MA 02142
Business Address
Wang Luhua (Reporting) CIK: 0001847910 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-36866 | Film No.: 21705456